IMPELLA ECP

Use of the Impella ECP in Patients Undergoing an Elective or Urgent High-Risk Percutaneous Coronary Intervention

Objective

This is a prospective, multi-center, single-arm study evaluating the major adverse cardiovascular and cerebrovascular event (MACCE) rate of the Impella ECP device in adult patients undergoing elective or urgent high-risk percutaneous coronary intervention (HRPCI).

Eligibility

  • Age ≥18 years and ≤90 years
  • Subject signed the informed consent
  • Subject is hemodynamically stable and a heart team, including a cardiac surgeon, has determined that an elective or urgent (not emergent) high-risk PCI is the appropriate therapeutic option

NCT ID

NCT05334784

Want to learn more? Visit ClinicalTrials.Gov.

Principal Investigator(s)
Status
Closed to Enrollment, No Patients in Follow-Up
Start Date
Completion Date